It is not clear whether infection with cytomegalovirus (CMV) is associated with hypertensive disorders in pregnant women. Through a case-control study design, 146 women suffering from hypertensive disorders in pregnancy (cases) and 146 age-matched normotensive pregnant women (controls) were examined for the presence of anti-CMV IgG and IgM antibodies with enzyme-linked immunoassays. IgM seropositive samples were further assayed by enzyme-linked fluorescent assay (ELFA).
Anti-CMV IgG antibodies were found in 138 (94.5%) controls and in 136 (93.2%) cases (odds ratio [OR] = 0.78; 95% confidence interval [CI]: 0.30–2.05; P = 0.62). High (>18 IU/ml) levels of anti-CMV IgG antibodies were found in 37.7% of the 138 seropositive controls and in 34.6% of the 136 seropositive cases (OR = 0.87; 95% CI: 0.53–1.43; P = 0.59). Anti-CMV IgM antibodies were found in 1 (0.7%) of the controls but in none of the cases using ELFA (P = 1.0). Seropositivity to CMV was not associated with a previous preeclampsia and was similar among cases regardless their mean systolic and diastolic blood pressures, and mean arterial blood pressure.
No serological evidence of an association between CMV infection and hypertensive disorders of pregnancy was found. Further research to elucidate the role of CMV in hypertensive disorders in pregnancy should be conducted.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Hanley PJ , Bollard CM: Controlling cytomegalovirus: helping the immune system take the lead. Viruses 6, 2242–2258 (2014)
-
2.
de Jong MD , Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA: Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 39, 141–162 (1998)
-
3.
Lindholm PF , Annen K, Ramsey G: Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets 11, 45–56 (2011)
-
4.
Goodrum F , Caviness K, Zagallo P: Human cytomegalovirus persistence. Cell Microbiol 14, 644–655 (2012)
-
5.
Cannon MJ , Schmid DS, Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20, 202–213 (2010)
-
6.
Foti G , Hyeraci M, Kunkar A, Ieropoli G, Sofo D, De Lorenzo S, Carpentieri MS: Cytomegalovirus infection in the adult. Minerva Med 93, 109–117 (2002)
-
7.
Hyde TB , Schmid DS, Cannon MJ: Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 20, 311–326 (2010)
-
8.
Kenneson A , Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17, 253–276 (2007)
-
9.
Manicklal S , Emery VC, Lazzarotto T, Boppana SB, Gupta RK: The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26, 86–102 (2013)
-
10.
Buonsenso D , Serranti D, Gargiullo L, Ceccarelli M, Ranno O, Valentini P: Congenital cytomegalovirus infection: current strategies and future perspectives. Eur Rev Med Pharmacol Sci 16, 919–935 (2012)
-
11.
Johnson J , Anderson B, Pass RF: Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol 55, 521–530 (2012)
-
12.
Laifer SA , Ehrlich GD, Huff DS, Balsan MJ, Scantlebury VP: Congenital cytomegalovirus infection in offspring of liver transplant recipients. Clin Infect Dis 20, 52–55 (1995)
-
13.
Rana S , Venkatesha S, DePaepe M, Chien EK, Paglia M, Karumanchi SA: Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol 109, 549–552 (2007)
-
14.
Higgins L , Vause S, Tower C: Cytomegalovirus infection in association with early onset pre-eclampsia. BMJ Case Rep 2010, bcr0320102803 (2010)
-
15.
Fajardo-Dolci G , Meljem-Moctezuma J, Vicente-González E, Venegas-Páez FV, Villalba-Espinoza I, Pérez-Cardoso AL, Barrón-Saldaña DA, Montesinos-Gómez G, Aguirre Güemez AV, Novoa-Boldo A, Mendoza-Larios LA, López-González R, Mazón-González B, Aguirre-Gas HG: Analysis of maternal deaths in Mexico occurred during 2009. Rev. Med. Inst. Mex. Seguro Soc 51, 486–495 (2013)
-
16.
Jido TA , Yakasai IA: Preeclampsia: a review of the evidence. Ann. Afr. Med 12, 75–85 (2013)
-
17.
Lo JO , Mission JF, Caughey AB: Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol, 25, 124–132 (2013)
-
18.
Anderson UD , Olsson MG, Kristensen KH, Åkerström B, Hansson SR: Review: biochemical markers to predict preeclampsia. Placenta 33, S42–47 (2012)
-
19.
Abalos E , Cuesta C, Grosso AL, Chou D, Say L: Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170, 1–7 (2013)
-
20.
Soydinc HE , Kan I, Dal T, Evsen MS, Sak ME, Ozler A, Turgut A, Yildiz I: Evaluation of the relationship between preeclampsia and seropositivity of infectious disease in maternal plasma. Clin Ter 164, e199–202 (2013)
-
21.
Zhang JF , Zhang WY: Relationship of cytomegalovirus, Chlamydia pneumoniae and herpes simplex virus type 2 infections with preeclampsia. Zhonghua Yi Xue Za Zhi 92, 1413–1415 (2012)
-
22.
Strand KM , Odland ML, Iversen AC, Nordbø SA, Vik T, Austgulen R: Cytomegalovirus antibody status at 17–18 weeks of gestation and pre-eclampsia: a case-control study of pregnant women in Norway. BJOG 119, 1316–1323 (2012)
-
23.
von Dadelszen P , Magee LA, Krajden M, Alasaly K, Popov ska V, Devarakonda RM, Money DM, Patrick DM, Brunham RC: Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 110, 725–730 (2003)
-
24.
Xie F , Hu Y, Magee LA, Money DM, Patrick DM, Krajden M, Thomas E, von Dadelszen P; Toxemia Study Group: An association between cytomegalovirus infection and preeclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand 89, 1162–1167 (2010)
-
25.
Xie F , von Dadelszen P, Nadeau J: CMV infection, TLR-2 and-4 expression, and cytokine profiles in early-onset preeclampsia with HELLP syndrome. Am J Reprod Immunol 71, 379–386 (2014)
-
26.
Alvarado-Esquivel C , Vázquez-Alaníz F, Sandoval-Carrillo AA, Salas-Pacheco JM, Hernández-Tinoco J, Sánchez-Anguiano LF, Liesenfeld O: Lack of association between Toxoplasma gondii infection and hypertensive disorders in pregnancy: a case-control study in a Northern Mexican population. Parasit Vectors 7, 167 (2014)
-
27.
Alvarado-Esquivel C , Hernández-Tinoco J, Sánchez-Anguiano LF, Ramos-Nevárez A, Cerrillo-Soto SM, Estrada-Martínez S, Martínez-Ramírez L, Pérez-Álamos AR, Guido-Arreola CA: Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico. BMC Infect Dis 14, 484 (2014)
-
28.
Tang N , Li JW, Liu YM, Zhong H, Wang LM, Deng FM, Qu YY, Hui J, Cheng J, Tang B, Huang G, Guo SX, Li XZ, Wei LL, He F: Human cytomegalovirus infection is associated with essential hypertension in Kazakh and Han Chinese populations. Med Sci Monit 20, 2508–2519 (2014)
-
29.
Hui J , Qu YY, Tang N, Liu YM, Zhong H, Wang LM, Feng Q, Li Z, He F: Association of cytomegalovirus infection with hypertension risk: a meta-analysis. Wien Klin Wochenschr 128, 586–591 (2016)
-
30.
Weber B , Berger A, Rabenau H. Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection. J Virol Methods 96, 157–170 (2001)
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Sep 2020 | 0 | 2 | 0 |
| Oct 2020 | 0 | 1 | 1 |
| Nov 2020 | 0 | 8 | 3 |
| Dec 2020 | 0 | 4 | 3 |
| Jan 2021 | 0 | 1 | 1 |
| Feb 2021 | 0 | 2 | 3 |
| Mar 2021 | 0 | 0 | 0 |
Copyright Akadémiai Kiadó
AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory